Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Class II · Moderate risk

Atorvastatin Calcium Tablets

Presence of Foreign Substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle.

Terminated Particulate / foreign matter Dr. Reddy's Laboratories, Inc. NDC 55111-124-90 D-0878-2018
Class III · Low risk

Nystatin Oral Suspension

Resuspension problems: Out of specification for appearance and resuspendability.

Terminated Failed specification Pharmaceutical Associates Inc NDC 0121-4810-05 D-0865-2018
Class III · Low risk

Valsartan Tablets USP

Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).

Terminated Chemical / undeclared Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-363-90 D-0876-2018
Class II · Moderate risk

Acne Shave

CGMP Deviations: products may be contaminated with bacteria.

Terminated Microbial contamination Shadow Holdings DBA Bocchi Labs D-0860-2018

Recalls by year